Association Study of the ATP - Binding Cassette Transporter A1 (ABCA1) Rs2230806 Genetic Variation with Lipid Profile and Coronary Artery Disease Risk in an Iranian Population by Ghaznavi, Habib et al.
 
Open Access Maced J Med Sci electronic publication ahead of print,  
published on February 11, 2018 as https://doi.org/10.3889/oamjms.2018.063 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                          1 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 
https://doi.org/10.3889/oamjms.2018.063 
eISSN: 1857-9655 
Basic Science 
 
 
  
 
Association Study of the ATP - Binding Cassette Transporter A1 
(ABCA1) Rs2230806 Genetic Variation with Lipid Profile and 
Coronary Artery Disease Risk in an Iranian Population 
 
 
Habib Ghaznavi
1
, Ehsan Aali
2
, Mohammad Soleiman Soltanpour
3* 
 
1
Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran; 
2
Department of 
Pharmacology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran; 
3
Department of Medical Laboratory 
Sciences, School of Paramedical Sciences , Zanjan University of Medical Sciences, Zanjan, Iran 
 
Citation: Ghaznavi H, Aali E, Soltanpour MS. 
Association Study of the ATP - Binding Cassette 
Transporter A1 (ABCA1) Rs2230806 Genetic Variation 
with Lipid Profile and Coronary Artery Disease Risk in an 
Iranian Population. Open Access Maced J Med Sci. 
https://doi.org/10.3889/oamjms.2018.063 
Keywords: ATP - binding cassette transporter A1; 
Polymerase chain reaction-restriction fragment length 
polymorphism; R219K mutation; Coronary artery disease 
*Correspondence: Mohammad Soleiman Soltanpour. 
Department of Medical Laboratory Sciences, School of 
Paramedical Sciences , Zanjan University of Medical 
Sciences, Zanjan, Iran. E-mail: soltanpour86@gmail.com 
Received: 06-Oct-2017; Revised: 11-Dec-2017; 
Accepted: 12-Dec-2017; Online first: 11-Feb-2018 
Copyright: © 2018 Habib Ghaznavi, Ehsan Aali, 
Mohammad Soleiman Soltanpour. This is an open-access 
article distributed under the terms of the Creative 
Commons Attribution-NonCommercial 4.0 International 
License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
 
 
 
 
 
 
Abstract  
BACKGROUND: ATP - binding cassette transporter A1 (ABCA1) plays essential roles in the biogenesis of high -
density lipoprotein - cholesterol. Variations in the ABCA1 gene may influence the risk of coronary artery disease 
(CAD). 
AIM: Present study aimed to investigate the association of rs2230806 (R219K) polymorphism of ABCA1 gene 
with the development and severity of CAD in an Iranian population. 
MATERIALS AND METHODS: Our study population consisted of 100 patients with angiographically confirmed 
CAD and 100 controls. The genotyping of R219K mutation of ABCA1 gene was determined by PCR - RFLP 
method. Lipid profile was determined using routine colourimetric assays. Statistical analysis was done by SPSS - 
16. 
RESULTS: The genotypic (P = 0.024) and allelic (P = 0.001) distribution of the ABCA1 R219K polymorphism 
were significantly different between the two groups. In a univariate analysis (with genotype RR as the reference), 
the RK genotype (OR = 0.46, 95%CI = 0.25-0.86, P = 0.020) and KK genotype (OR = 0.27, 95%CI = 0.11 – 0.66, 
P = 0.005) was significantly associated with a decreased risk of CAD. A multiple logistic regression analysis 
revealed that smoking (0.008), diabetes (P = 0.023), triglyceride (P = 0.001), HDL - cholesterol (P = 0.002) and 
ABCA1 KK genotype (P = 0.009) were significantly and independently associated with the risk of CAD. The 
association between different genotypes of R219K polymorphism with lipid profile was not significant in both 
groups (P > 0.05). The R219K polymorphism was significantly associated with severity of CAD (P < 0.05). 
CONCLUSION: The carriage of K allele of ABCA1 R219K polymorphism has a protective effect on CAD risk and 
correlates with a decreased severity of CAD. This protective effect seems to be mediated independently of 
plasma lipid levels. 
 
 
 
 
 
 
 
Introduction 
 
Coronary artery disease (CAD) is considered 
as one of the main leading causes of morbidity and 
mortality in Iranian population. Several 
epidemiological studies have indicated a strong 
inverse association between high-density lipoprotein 
cholesterol (HDL - C) levels and CAD occurrence 
[1][2]. Low levels of HDL-C in plasma are considered 
as an independent risk factor for CAD development 
[3]. The circulating levels of HDL - C are determined 
by the interaction of both environmental and genetic 
factors. Genetic factors contribute considerably (up to 
60%) for plasma HDL - C levels and some genes 
including ATP - binding cassette transporter A1 
(ABCA1) have been associated with its plasma 
concentration [4][5]. 
The ABCA1 is a membrane transporter 
protein that plays an essential role in the efflux of 
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cholesterol from peripheral tissues back to the liver. 
The ABCA1 transporter functions in the initial step of 
revers cholesterol transfer and transfers cholesterol 
and phospholipid from peripheral tissues to lipid-poor 
apolipoprotein AI, creating nascent high - density 
lipoprotein particles [6]. Reduced activity of the 
ABCA1 transporter leads to disturbances in plasma 
lipid composition and levels which are common 
findings in patients with CAD [6].  
Reduced HDL - C level is the most common 
lipoprotein abnormality observed among CAD patients 
and is a major determinant of morbidity and mortality 
rate in these patients [7][8]. Genetic and molecular 
biology studies have shown that common 
polymorphisms in the ABCA1 gene can influence the 
function of ABCA1 transporter resulting in the altered 
biosynthesis of HDL - C particles [9][11]. Reduced 
function of the ABCA1 transporter may be involved in 
the pathogenesis of CAD. The R219K (rs2230806, 
107620867C>T) common polymorphism in the 
ABCA1 gene is located in the two major extracellular 
loops of ABCA1 protein, which has a critical role for 
interaction with apoA - I and for cholesterol efflux 
[12][13]. Therefore, it is likely that the R219K variant 
acts as a functional mutation to modulate HDL - C 
level [12]. The R219K polymorphism may affect the 
development and severity of CAD via altering the lipid 
profile [14]. Numerous studies have investigated the 
association of R219K mutation of ABCA1 gene and 
the development of CAD in different populations 
[9][10][15]. However, in-consistent results have been 
reported [9][10][14][15][16]. The aim of the present 
study was to investigate the role of ABCA1 rs2230806 
genetic polymorphism in the development of CAD 
from an Iranian population. Also, the effect of the 
ABCA1 rs2230806 common polymorphism on lipid 
profile was investigated in CAD patients and control 
subjects.  
 
 
Material and Methods  
 
Study Population 
Our study population consisted of 200 
subjects including 100 patients (50 male and 50 
female) with a confirmed diagnosis of CAD and 100 
matched controls (50 male and 50 female). The mean 
age of CAD patients and controls were 58.96 ± 11.54 
and 57.53 ± 16.1, respectively. The CAD diagnosis 
was made by angiography conducted by an expert 
cardiovascular specialist. The minimum required 
criteria for including of CAD patients in the study were 
the presence of more than 50% stenosis in at least 
one major coronary vessel. The severity of CAD was 
determined based on the number of the stenotic 
vessel showing ≥ 50% stenosis. Accordingly, patients 
were classified as single, double and triple vessel 
stenosis patients. Patients showing fewer than 50% 
stenosis or taking lipid-lowering drugs were excluded 
from the study. Patients suffering from valvular heart 
disease, cardiomyopathy, autoimmune disorders, 
inflammatory disease, infectious disease, renal, heart 
and liver failures and cancer were excluded from the 
study. Control subjects were selected randomly after 
careful inspection of a cardiovascular specialist. 
Control subjects were included in the study if they had 
no personal or family history of CAD or other reasons 
to suspect CAD. Also, control subjects with overt 
concomitant diseases such as malignant diseases, 
autoimmune disease, infectious disease and organ 
failure were excluded. For all subjects, complete 
medical history including questions about smoking 
habits, history of hypertension and diabetes and 
family history of heart disease was obtained by 
questionnaire. Diabetes was defined by fasting blood 
glucose > 126 mg/dL, and hypertension was defined 
by systolic blood pressure >140 mmHg and/or 
diastolic blood pressure >90 mmHg. All of the study 
subjects participated voluntarily in the study and 
written informed consent was obtained from all 
participants. The study was approved by ethical 
committee of Zahedan University of Medical Sciences 
(Ethical committee code: IR.ZAUMS.REC.1394.383), 
Zahedan, Iran. 
 
Blood Samples Collection 
From each participant, 5 ml fasting blood 
were collected in EDTA containing tubes and instantly 
centrifuged. Plasma fraction was separated and 
stored at -40ºC and the cellular fraction was used for 
DNA extraction. 
 
ABCA1 R219K Polymorphism Analysis 
Genomic DNA was purified from blood 
leukocytes using a commercially available DNA 
extraction kit (Viogene, Poland). The genotyping of 
ABCA1 gene R219K polymorphism was conducted by 
PCR reaction at an annealing temperature of 62ºC. 
The sequence of primers were obtained from previous 
studies [17] and was as follows: forward 5' – 
AAAGACTTCAAGGACCCAGCTT - 3' and reverse 5' - 
CCTCACATTCCGAAAGCATTA - 3'. After 
amplification, a seven microliter aliquot of PCR 
product was digested with 5u EcoN1 restriction 
enzyme (Fermentas, Inc, Germany) for at least 8 
hours at 37 °C. The obtained fragments after 
restriction digestion were separated on 2.5% agarose 
gel and stained with Sybr green dye. After digestion, 
the 309bp PCR amplicon cleaves into 184 and 125 bp 
fragments in the presence of K allele whereas the R 
allele produces a single non - digested 309 bp 
fragment. Genotyping results from ten percent of 
samples determined by PCR - RFLP method was 
randomly confirmed by direct sequencing of PCR 
products (Figure 1). 
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Figure 1: Results of direct sequencing of PCR products showing 
wild (C) and mutant (T) allele of ABCA1 R219K polymorphism 
 
Biochemical Methods 
Plasma total cholesterol (TC), Triglycerides 
(TG), high-density lipoprotein- cholesterol (HDL - C), 
low-density lipoprotein cholesterol (LDL - C) and 
fasting glucose levels were measured with 
commercially available enzyme assay kits (Pars 
Azmon Co, Tehran, Iran) using Mindray autoanalyser 
(BS-200).  
 
Statistical Analysis  
In descriptive statistics, numerical variables 
presented as mean ± SD and were compared using 
Student t-test. Categorical variables were compared 
with Chi-square test or Fisher exact test (in case of 
small sample size).  The deviation of genotype 
distribution from the Hardy - Weinberg equilibrium 
(HWE) was assessed in both patients and controls by 
Chi-square test. Multivariate logistic regression 
analysis was performed to determine the independent 
association of each covariate with the risk of a CAD. 
The statistical analysis with a P value < 0.05 was 
considered significant. All statistical analysis was 
performed using SPSS 16 software. 
 
 
Results 
 
The comparison of clinical and biochemical 
parameters of the CAD patients and control subjects 
revealed no statistically significant differences in the 
mean ages and sex distribution between CAD group 
and control group (P = 0.471; P = 1.000, respectively). 
However, plasma levels of TC, TG and LDL - C were 
significantly higher while the plasma levels of HDL - C 
were significantly lower in CAD group compared with 
control group. Moreover, the presence of diabetes (P 
= 0.014), hypertension (P = 0.009) and smoking habit 
(P = 0.002) were significantly more common in CAD 
group than control group (Table 1). Also, statistical 
analysis using Chi-square test indicated that the 
genotype distribution of ABCA1 R219K polymorphism 
was significantly different between the two groups (P 
= 0.024, 
2
= 13.6) (Table 1).  
Table 1: Clinical characteristics of the CAD group and control 
group included in the study 
Variables CAD group 
n=100 
Control group 
n=100 
P value 
Age (years) 58.96 ± 11.54 57.53 ± 16.1 0.471 
Sex (M/F) 50/50 50/50 1.000 
TG (mg/dl) 202.21 ± 90.02 162.17 ± 69.67 0.001 
TC (mg/dl) 200.78 ± 58.13 173.57 ± 40.13 <0.001 
HDL-C (mg/dl) 39.17 ±8.45 45.39 ± 12.62 <0.001 
LDL-C (mg/dl) 114.98± 44.43 96.97 ± 34.51 0.002 
Hypertension (n.%) 23 (23%) 8 (8%) 0.009
*
 
Diabetes (n.%) 24 (24%) 10 (10%) 0.014
*
 
Smoking (n.%) 33 (33%) 12 (12%) 0.002
* 
R219K genotypes 
RR:RK:KK 
50:40:10 29:50:21 0.024 
CAD:  Coronary artery disease, TC: total cholesterol, TG: Triglyceride, HDL: High - density 
lipoprotein - cholesterol, LDL: Low - density lipoprotein- cholesterol.
* 
P value determined 
by Fisher exacts test. 
 
The frequency of RR, RK and KK genotypes 
among the CAD group was 50.0%, 40.0%, and 
10.0%, respectively, and among the control group was 
29.0%, 50.0% and 21.0%, respectively (Table 2). The 
χ2 test showed that the genotype distribution of 
ABCA1 gene R219K polymorphism were in 
coincidence with the Hardy - Weinberg equilibrium in 
both CAD patients (P = 0.63) and controls (P = 0.98). 
In a univariate analysis (with genotype RR as 
reference) the RK genotype (OR = 0.46, 95% CI: 0.25 
- 0.86; P = 0.020) and KK genotype (OR = 0.27, 95% 
CI: 0.11-0.66; P = 0.005) was significantly correlated 
with a decreased risk of CAD (Table 2). Also, the 
frequency of minor K allele of ABCA1 R219K 
polymorphism was significantly lower in CAD group 
compared with control group (30% vs. 46%; OR = 
0.50; 95% CI: 0.33-0.75; P = 0.001). 
Table 2: Prevalence of ABCA1 R219K allele and genotypes in 
CAD group and control group 
ABCA1 R219K  
Polymorphism 
CAD group
 
(n=100) 
Control group
 
(n=100) 
OR (95%CI) P value
* 
 
  
 
Ref 
 
0.50 (0.33-0.75) 
 
- 
 
0.001 
R allele 
 
140 (70.0%) 108 (54.0 %) 
K allele 60 (30.0%) 92 (46.0%) 
 
RR 
 
 
50 (50%) 
 
29 (29%) 
 
Ref 
 
- 
RK 
 
40 (40%) 50 (50%) 0.46 (0.25-0.86) 0.020 
KK 10 (10%) 21 (21%) 0.27 (0.11-0.66) 0.005 
 
CAD:  Coronary artery disease, RR: Wild-type, RK: Heterozygote; KK: Homozygote; 
* 
P 
values were determined by Fisher's exact test.   
 
 In a multiple binary logistic regression 
analysis using the study group (CAD group vs. control 
group) as the dependent variable and using age, sex, 
TG, TC, HDL - C, LDL - C, smoking, diabetes, 
hypertension and R219K genotypes as covariates, the 
KK genotype of ABCA1 R219K polymorphism was 
independently associated with a decreased risk of 
CAD (OR = 0.212, 95% CI: 0.069 - 0.653; P = 0.009) 
but the RK genotype was not (OR = 0.430, 95% CI: 
0.194-0.954; P = 0.074). Also, TG levels (P = 0.001), 
HDL - C levels (P = 0.002), diabetes (P = 0.023) and 
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smoking (P = 0.008) were significant risk factor for 
CAD development. However, TC levels (P = 0.245), 
LDL - C levels (P = 0.644) and hypertension (P = 
0.279) didn’t show any significant association with 
CAD risk in regression analysis (Table 3).  
Table 3: Multiple Logistic regression analysis of association 
between the ABCA1 R219K genotypes and risk of coronary 
artery disease 
Variable  Wald Odd ratio 95% CI P value 
Age 0.075 0.997 0.973-1.021 0.785 
Sex 0.622 1.321 0.662-2.636 0.430 
Hypertension 1.198 1.740 0.639- 4.741 0.279 
Diabetes 5.097 2.881 1.154-7.175 0.023 
Smoking 6.889 3.134 1.349-7.281 0.008 
TG 10.181 1.009 1.003-1.014 0.001 
TC 1.353 1.009 0.994-1.023 0.245 
HDL-C 7.959 0.951 0.918-0.985 0.002 
LDL-C 0.001 1.000 0.982-1.019 0.644 
RK vs. RR 4.313 0.430 0.194-0.954 0.074 
KK vs. RR 7.302 0.212 0.069-0.653 0.009 
 
Furthermore, the association of different 
genotypes of ABCA1 R219K polymorphism with lipid 
profile was presented in Table 4. As shown, no 
significant differences were observed in the lipid 
distribution according to the different genotypes of 
ABCA1 R219K polymorphism in CAD group and 
control group.  
Table 4: Lipid profile distribution among different genotypes of 
ABCA1 R219k polymorphism 
Parameter                           Controls
* 
                               Cases
†
 
RR RK KK RR RK KK 
 TG   mean  
(SD) 
162.2 
(91.7) 
162.4 
(42.6) 
161.6 
(88.3) 
192.1 
(95.3) 
215.1 
(91.3) 
185.9 
(38.5) 
TC    mean  
(SD) 
181.9 
(33.6) 
173.8 
(43.4) 
160.6 
(39.0) 
196.9 
(53.1) 
197.6 
(57.5) 
232.7 
(79.3) 
HDL-C  mean 
(SD) 
43.3 
(12.7) 
46.6  
(13.4) 
45.3  
(10.5) 
38.4  
(8.1) 
40.5  
(9.2) 
37.6  
(6.6) 
LDL-C  mean 
(SD) 
108.4 
(32.6) 
94.7  
(33.9) 
86.5  
(35.6) 
123.0 
(39.7) 
107.3 
(47.4) 
105.4 
(51.4) 
*
One way ANOVA test showed insignificant differences in TG (P = 0.99), TC (P = 0.21), 
HDL-C (P = 0.53) and LDL - C (P = 0.06) levels according to different genotypes of R219K 
polymorphism.
 †
One way ANOVA test showed insignificant differences in TG (P = 0.31), 
TC (P = 0.18), HDL - C (P = 0.44) and LDL - C (P = 0.19) levels among different 
genotypes of R219K polymorphism. 
 
However, investigating the prevalence of 
different genotypes of ABCA1 R219K polymorphism 
between patients with one and two or three stenotic 
vessels revealed significant differences in the 
genotype distribution between them (P < 0.05) (Table 
5). 
Table 5: The association of severity of CAD with the number of  
stenotic coronary vessels 
ABCA1 R219K 
genotypes 
1 SV 
N = 36 
2 SV 
N = 42 
3 SV 
N = 22 
P value
*
 
2 SV vs. 1SV 
P value
* 
3 SV vs. 1SV 
RR   12 (33.33%) 24 (57.14%) 14 (63.63%) Ref Ref 
RK   17 (47.22%) 17 (40.48%) 6 (27.27%) 0.225 0.080 
KK   7 (19.44%) 1 (2.38%) 02 (9.1%) 0.013 0.135
 
RK+KK 24 (66.67%) 18 (42.86%) 08 (36.36%) 0.042 0.031
* 
SV: Stenotic vessel, ABCA1: ATP - binding cassette transporter A1, RR: Wild-type, RK: 
Heterozygote; KK: Homozygote. * P values were calculated using Fisher's exact test,  
 
 
 
Discussion 
 
We found a significant association between 
the K allele of ABCA1 R219K polymorphism and a 
decreased susceptibility to CAD development in an 
Iranian population. Based on the present study, the 
carriers of K allele exhibited lower risk of CAD 
development than the carriers of R allele (OR = 0.50, 
95% CI = 0.33-0.75, P = 0.001) Also, the severity of 
CAD was significantly lower in K allele carriers of 
R219K polymorphism relative to homozygous carriers 
of R allele.  However, the association of R219K 
polymorphism with the lipid profile didn’t show any 
significant association.   
The association of an R219K polymorphism of 
ABCA1 gene with CAD risk and lipid profile has been 
investigated in several studies. The study by Abd El-
Aziz et al. reported that the K allele of ABCA1gene 
confers protection against CAD development [10]. In 
another study by Yin et al., it was shown that carriers 
of K allele relative to carriers of R allele of R219K 
polymorphism of ABCA1 gene had a significantly 
lower risk for progression of atherosclerosis (P < 0.01) 
[18]. Also, the study by Benton et al. conducted in the 
United States indicated that the KK genotype of 
R219K polymorphism was associated with slightly 
higher HDL - C and thus may protect against 
subclinical cardiovascular disease [19]. Interestingly, 
in a recently published study by Au et al., it was 
shown that ABCA1 R219K K variant allele may 
associate with decreased risk of cerebrovascular 
disease, and thus provided further evidence for the 
protective effects of ABCA1 R219K K variant allele on 
the development of another vascular disease such as 
cerebrovascular disease [20].  
By these studies, the current study 
demonstrated a lower risk of CAD development in a 
carrier of K allele than carriers of R allele of ABCA1 
R219K polymorphism. On the contrary, Rejeb et al. 
didn’t find any significant association between R219K 
polymorphism and CAD risk in a Tunisian population 
[9]. Moreover, Li et al concluded that the R219K 
polymorphism does not seem to influence CAD risk in 
a China population [13]. Also, the study by Cyrus et al 
in a Saudi Arabians population identified that the KK 
genotype of ABCA1 R219K polymorphism acts as a 
promoting risk factor for CAD development [16]. There 
are several possible speculations for the inconsistent 
results of association studies. Some of these 
controversies may be related to different genetic 
background and genetic diversity among ethnicities. 
Ethnic differences may influence the impact of this 
polymorphism on CAD risk [11]. Indeed, a recently 
published study by Liu et al indicated interethnic 
differences in the genotype distribution of R219K 
genetic polymorphism and demonstrated that this 
genetic variant acts as a significant protective factor 
against CAD development in Asian population but not 
in some Caucasians populations [21]. Also, 
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population-specific linkage disequilibrium between 
markers loci and disease-susceptibility loci, 
confounding sampling bias, sample selection criteria, 
variation in study design, misclassification of 
phenotypes, gene-gene and gene-environment 
interactions are other factors that influence genetic 
association results [22]. Moreover, a great difference 
in the K allele frequency of R219K polymorphism was 
seen in various ethnic groups that may influence the 
consistency of association studies [19][23].  
Increased circulating level of HDL - C is a 
significant protective factor against CAD development. 
HDL - C deficiency is the most common lipid 
abnormality observed among patients with premature 
CAD [10]. At least 50% of HDL - C levels are 
determined by genetic factors [4]. ATP - binding 
cassette transporter A1 (ABCA1) is shown to play an 
essential role in the HDL-C biosynthesis by efflux of 
cellular cholesterol to apolipoprotein - A1. The effect 
of R219K polymorphism of ABCA1 gene on lipid 
profile has been studied extensively with discrepant 
results [9][14][17][24][25]. Our study didn’t find any 
significant association between this common 
polymorphism and TG, TC, HDL - C and LDL - C 
levels. In accordance with present study, some other 
studies also reported no significant association 
between the K allele of ABCA1 R219K polymorphism 
and serum HDL - C levels and TG levels [17][23][25] 
However, some other studies reported this common 
polymorphism as a significant contributing factor for 
the plasma lipid levels [9][19][24]. Recently, a study by 
Rejeb et al. reported that the K allele was significantly 
associated with a higher mean HDL - C concentration 
[9]. Also, another study by Mokuno et al. reported that 
the mean HDL - C level was slightly higher in KK 
genotype than in RR genotype in both men and 
women [24]. Moreover, the study by Benton et al. 
demonstrated higher HDL - C level and lower LDL - C 
and TG levels in carriers of homozygote KK genotype 
[19]. 
The causes for the discrepant association of 
ABCA1 R219K polymorphism with lipid profile in 
different studies remains to be determined. However, 
the interaction between genetic and environmental 
factors plays an essential role in determining the lipid 
profile. So, the variation in environmental factors such 
as geographic distribution, climate, diet, lifestyle and 
socioeconomic status may modify the effect of ABCA1 
R219K polymorphism on lipid profile which can 
explain the inconsistencies among different studies 
[4][11].  
On the other hand, some other studies 
including the current study have reported a significant 
association of K allele of ABCA1 R219K 
polymorphism with a decreased risk of CAD 
development independent of serum lipid levels 
[21][26]. According to some studies, cholesterol efflux 
capacity has been associated with carotid intima-
media thickness and the risk of cardiovascular 
disease independent of HDL-C levels [27, 28]. So, the 
independent association of K allele of ABCA1 R219K 
polymorphism with decreased susceptibility to CAD 
development may be attributed to increased 
cholesterol efflux capacity seen in K allele carriers of 
R219K polymorphism [29]. Recently, in a study by 
Villard et al., it was shown that cholesterol efflux 
capacity is significantly and inversely associated with 
an incident of coronary heart events independent of 
established cardiovascular risk factors including the 
HDL cholesterol or apoA-I concentrations [30].  
The present study bears some limitations as 
follows (i) The cholesterol efflux capacity and its 
association with different genotypes of ABCA1 R219K 
polymorphism were not determined (ii) The plasma 
concentration of Apo-A and Apo-B were not measured 
(iii)  The other polymorphisms of ABCA1 gene and 
their interaction with R219K polymorphism were not 
determined. 
In conclusion, the carriage of K allele of the 
ABCA1 R219K polymorphism has a protective effect 
on CAD development and correlates with a decreased 
severity of CAD. This protective effect of the K allele 
seems to be mediated independently of plasma lipid 
levels.   
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